Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices

Abstract

Colorectal cancer (CRC) is a feared complication of inflammatory bowel disease (IBD). The cumulative probability of developing this malignancy is significantly higher than in the general population, making IBD the third highest risk condition for CRC. Since CRC is such a concerning complication, it should be no surprise that patients and physicians want to know what the most important risk factors are for its development, as well as potential strategies for reducing these risks. This article reviews the current practice and emerging technologies for detecting and preventing colon cancer in patients with IBD.

Keywords::

• chemoprevention
• chromoendoscopy
• colon cancer
• colonoscopy
• dysplasia

Financial & competing interests disclosure

F Velayos has received research support from Procter and Gamble and honoraria from Procter and Gamble Pharmaceuticals and Shire Pharmaceuticals. This publication was supported by NIH/NCRR/OD UCSF-CTSI Grant Number KL2 RR024130. Its contents are solely the responsibility of the author and do not necessarily represent the official views of the NIH. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Notes

Adapted from [10].